On March 16 2009 mandatory notifications of trade in DiaGenic ASA took place.
Director, board member and primary insider Praveen Sharma has sold 185.000 shares at NOK 2,50 per share. After the transaction Sharma controls a total of 2.985.000 shares in DiaGenic.
These shares are acquired by:
Morten Sten Johansen, International Business Director and primary insider, har aquired 120.000 aksjer at NOK 2,50 per share. After this transaction Morten Sten Johansen owns 120.000 shares in Diagenic.

Håkon Sæterøy, primary insider and Executive Chairman of the Board of DiaGenic ASA, has acquired 40.000 shares at NOK 2,50 per share. Sæterøy`s overall exposure in the Company after the purchase is a total of 1.343.478 shares.
Ken Bårdsen, Molecular Biologist in DiaGenic, has purchased 25.000 shares at NOK 2,50 per aksje. After this purchase Bårdsen owns 70.000 shares in DiaGenic.

MD PhD Erik Christensen, Managing Director
Telephone: +47 95939918

About Us

Nel is a global, dedicated hydrogen company, delivering optimal solutions to produce, store, and distribute hydrogen from renewable energy. We serve industries, energy, and gas companies with leading hydrogen technology. Our roots date back to 1927, and since then, we have had a proud history of development and continual improvement of our hydrogen plants. Today, our hydrogen solutions cover the entire value chain: from hydrogen production technologies to hydrogen fueling stations, enabling industries to transition to green hydrogen, and providing fuel cell electric vehicles with the same fast fueling and long range as fossil-fueled vehicles… without the emissions.